DALY II Japan/MB-CART2019.1 for DLBCL
DALY II Japan/MB-CART2019.1 for DLBCL
Recruiting · NCT07288879 · Registry updated 2026-01-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| DALY II Japan/MB-CART2019.1 for DLBCL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, histiocytosis, interdigitating dendritic cell sarcoma, lymphatic system disorder, malignant histiocytosis, neoplasm | Recruiting | Phase 2 | 2026-01-08 | NCT07288879 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Miltenyi Biomedicine GmbH | 22 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Juntendo University Hospital | Tokyo | Japan | 26 |
| Keio University Hospital | Tokyo | Japan | 14 |
| National Cancer Center Hospital | Tokyo | Japan | 42 |
| Tokyo Metropolitan Komagome Hospital | Tokyo | Japan | 2 |
| Toranomon Hospital | Tokyo | Japan | 12 |